Edit
N-of-One.
https://n-of-one.com/Last activity: 22.07.2016
Active - Reference to QIAGEN Digital Insights
N-of-One is a personalized health IT and diagnostic interpretation company that provides oncologists with clinically actionable interpretation of genetics mutations that exist in a patient’s tumor
Status: Acquired by Qiagen in 2019.
Status: Acquired by Qiagen in 2019.
Location: United States, Massachusetts, Concord
Employees: 51-200
Total raised: $7M
Founded date: 2008
Investors 1
| Date | Name | Website |
| - | Excel Vent... | excelvm.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.07.2016 | Series B | $7M | - |
Mentions in press and media 6
| Date | Title | Description |
| 22.07.2016 | N-of-One Raises $7M for Precision Medicine Oncology Decision Support | N-of-One, a precision medicine oncology decision support company has raised $7 million in funding from Providence Ventures and Excel Venture Management. The latest round brings its total funding to $11M. Founded in 2008 by a team of PhD sci... |
| 22.07.2016 | N-of-One’s new funding will expand precision medicine clinical decision support in China, Europe | Cournoyer said the Lexington, Massachusetts company has raised $14 million to date. Some of the angel investors that backed N-of-One’s $7 million series A round returned for the series B, in which it secured institutional investment from Pr... |
| 21.07.2016 | N-of-One Raises $7 Million Series B | N-of-One, a precision medicine oncology decision support company, announced today that it has received $7 million in a Series B financing from Providence Ventures and Excel Venture Management. The financing will be used to expand the compan... |
| 21.07.2016 | N-of-One Secures $7M in Series B Financing | N-of-One, a Lexington, Mass.-based precision medicine oncology decision support company, received $7m in Series B funding. Backers included Providence Ventures and Excel Venture Management. The company intends to use the funds to expand its... |
| 21.07.2016 | N-of-One Raises $7M | LEXINGTON, MA, N-of-One, a precision medicine oncology decision support company, announced today that it has received $7 million in a Series B financing from Providence Ventures and Excel Venture Management. >> Click here for more ... |
| - | N-of-One’s new funding will expand precision medicine clinical decision support in China, Europe | Christine Cournoyer, N-of-One CEO More than three years after the launch of its molecular diagnostics clinical decision support business, much has changed at N-of-One. The company has expanded its hospital customer base, from hospitals taki... |